Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SA53-OS |
| Synonyms | |
| Therapy Description |
SA53-OS binds MDM2 and blocks its interaction with p53, thereby restoring p53 activity, which may result in increased tumor cell apoptosis (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SA53-OS | SA53 OS|SA53OS|SA53-MDM2 | MDM2 Inhibitor 23 | SA53-OS binds MDM2 and blocks its interaction with p53, thereby restoring p53 activity, which may result in increased tumor cell apoptosis (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06578624 | Phase Ib/II | SA53-OS | Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors | Recruiting | USA | 0 |